Your Messages Inbox
Your Article Summary
See Latest ArticlesEndeavor Stent Reduced Risk of Heart Attack/Cardiac Death by 48% at Three Years Compared to Taxus Stent in Large Study
Medtronic, 09/22/09
Anticipating a change in the practice of interventional cardiology, Medtronic, Inc., announced that the latest findings from the ENDEAVOR IV clinical trial – a large study comparing two drug–eluting coronary stents head–to–head – demonstrate statistically and clinically significant differences in measures of safety between Medtronic's Endeavor zotarolimus–eluting stent and Boston Scientific's Taxus paclitaxel–eluting stent at three years of patient follow–up.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
The Unintended Consequences of Clinical Trials Regulations
PLoS Medicine, 12/04/09
Characterization of Baseline Methicillin-Resistant Staphylococcus aureus Isolates Recovered from Phase IV Clinical Trial for Linezolid
Journal of Clinical Microbiology, 12/03/09
Bayer Starts Phase III Trial with Florbetaben
BayNews International, 12/01/09
Article Search
Sponsor